News
Posted
All
| 2019 | 2018 | 2017 | 2016
Study Quantifies Impact of NCI-sponsored Trials on Clinical Cancer Care
A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI’s National Clinical Trials Network (... Read More
POSTED: 09/18/2019SOURCE: NCI Press Release
Michigan’s Philip Stella receives NCORP 2019 Harry Hynes Award: Conversation with the Cancer Letter
Philip J. Stella, the principal investigator of the Michigan Cancer Research Consortium NCI Community Oncology Research Program site in Ann Arbor, won the 2019 Harry Hynes Award. The award is given annually to NCORP PIs... Read More
POSTED: 09/13/2019SOURCE: The Cancer Letter
NCI Annual Plan & Budget Proposal for Fiscal Year 2021
The year 2021 will mark the 50th anniversary of the National Cancer Act of 1971, the landmark legislation that intensified support for cancer research in the United States. The investment sparked a biomedical revolution... Read More
POSTED: 09/05/2019SOURCE: NCI Director’s Message
The National Cancer Institute (NCI) has awarded 53 grants to researchers in the NCI Community Oncology Research Program (NCORP) to conduct multi-site cancer clinical trials and cancer care delivery studies in their... Read More
POSTED: 08/19/2019SOURCE: DCP News
Study Suggests Reviewing Lung Cancer Screening Criteria for African Americans
Clinical recommendations on who should be screened for lung cancer are based largely on how long a person smoked and the number of cigarettes they smoked. But current recommendations may need to be reviewed when it comes to... Read More
POSTED: 07/31/2019SOURCE: NCI Cancer Currents Blog
Volume 10, Issue 3 Dear Nutrition Enthusiast, The summer issue of Nutrition Frontiers showcases results of the VITAL trial – the Vitamin D and Omega-3 Trial, along with how cooked meat carcinogens affect prostate cancer.... Read More
POSTED: 07/25/2019SOURCE: DCP News
Why I choose to play a dual role in TMIST
By Worta McCaskill-Stevens As a physician-scientist, I have spent my career advancing research in women’s health. I was a part of the planning effort to design and launch TMIST—the Tomosynthesis Mammographic Imaging... Read More
POSTED: 05/24/2019SOURCE: The Cancer Letter
A new video from the National Cancer Institute (NCI) highlights the research efforts of the NCI Community Oncology Research Program (NCORP) in implementing cancer clinical trials and other research studies across the... Read More
POSTED: 05/16/2019SOURCE: DCP News
Prostate Cancer Prevention and Finasteride: A Conversation with NCI’s Dr. Howard Parnes
In 2003, results from the Prostate Cancer Prevention Trial (PCPT)—an NCI-funded randomized clinical trial with nearly 19,000 participants—showed that men aged 55 and older who used the drug finasteride daily for 7 years had... Read More
POSTED: 05/13/2019SOURCE: NCI Cancer Currents Blog
Volume 10, Issue 2 Dear Nutrition Enthusiast, The spring issue of Nutrition Frontiers showcases coffee, tea, caffeine and the risk of skin cancer, bitter melon’s potential as a novel pancreatic cancer chemotherapeutic... Read More
POSTED: 04/29/2019SOURCE: DCP News
Could a Vaccine Prevent Colorectal Cancer in People with Lynch Syndrome?
Researchers have taken the first steps toward developing a vaccine to prevent cancer in people with Lynch syndrome, an inherited condition that elevates a person’s risk of colorectal, endometrial, and other types of cancer.... Read More
POSTED: 04/19/2019SOURCE: NCI Cancer Currents Blog
TMIST PI Pisano: “Are we further reducing breast cancer mortality the more intensively we screen?”
The Tomosynthesis Mammographic Imaging Screening Trial, a massive randomized trial of early detection, is asking an important question: Is digital breast tomosynthesis better than digital mammography in reducing development... Read More
POSTED: 03/19/2019SOURCE: The Cancer Letter
NCI participated in the American Association for Cancer Research (AACR) Annual Meeting held March 29 - April 3, 2019 at Georgia World Congress Center in Atlanta, GA, including presenting the following research results from... Read More
POSTED: 03/15/2019SOURCE: DCP News
At 12 NCI Community Oncology Research Program (NCORP) sites across the United States, a new kind of study will soon be opening for patients with advanced malignancies being treated with molecularly targeted therapies. The... Read More
POSTED: 03/01/2019SOURCE: DCP News
After Lung Cancer Screening, Follow-Up Procedures May Be Riskier than Thought
Being screened for lung cancer can lead to follow-up diagnostic procedures, including invasive ones. The risk of complications from those invasive procedures may be higher than previously thought, a new study suggests. By... Read More
POSTED: 02/08/2019SOURCE: NCI Cancer Currents Blog
Volume 10, Issue 1 Dear Nutrition Enthusiast, The winter issue of Nutrition Frontiers celebrates the beginning of 2019 and showcases the potential beneficial effects of a dietary pattern of whole grains, legumes, fruits... Read More
POSTED: 01/24/2019SOURCE: DCP News
FHP Health Center in Guam was approved in January as the newest affiliate of the National Cancer Institute Community Oncology Research Program (NCORP) to bring cancer clinical trials and cancer care delivery studies to... Read More
POSTED: 01/24/2019SOURCE: DCP News
The Final Verdict on Finasteride
Finasteride, a generic hormone-blocking drug, was found to reduce the risk of prostate cancer by 25 percent in the landmark Prostate Cancer Prevention Trial (PCPT). Long- term data, published today in the New England Journal... Read More
POSTED: 01/23/2019SOURCE: SWOG News
Managing Cancer Pain: Are Better Approaches on the Horizon?
Pain is a common and much-feared symptom among people being treated for cancer and long-term survivors. Cancer pain can be caused by the disease itself, its treatments, or a combination of the two. It may be short-lived or... Read More
POSTED: 01/23/2019SOURCE: NCI Cancer Currents Blog
Hepatitis Goes Undiagnosed in Cancer Patients
Results from the largest study of hepatitis B and C and HIV infection prevalence in cancer patients show that an alarmingly high rate of undiagnosed acute and chronic hepatitis B and C. Hepatitis B and C are serious but... Read More
POSTED: 01/17/2019SOURCE: SWOG News
For Early-Stage Lung Cancer, Study Identifies Potential New Biomarker, Treatment Target
A new study has identified a potential biomarker of early-stage non–small cell lung cancer (NSCLC). The biomarker could help diagnose precancerous lung growths (called nodules or lesions) and early-stage lung cancers... Read More
POSTED: 01/03/2019SOURCE: NCI Cancer Currents Blog
The HPV Vaccine: Increasing the Use of an Important Cancer Prevention Tool
Last month, I released a report to the White House and the public, HPV Vaccination for Cancer Prevention: Progress, Opportunities, and a Renewed Call to Action. This report describes the progress that’s been made toward... Read More
POSTED: 12/20/2018SOURCE: NCI Cancer Currents Blog
Vitamin D Supplements Don’t Reduce Cancer Incidence, Trial Shows
In the largest-ever randomized clinical trial testing vitamin D for cancer prevention, the supplement did not reduce the risk of developing cancer. A large body of epidemiology research had suggested that people with higher... Read More
POSTED: 12/13/2018SOURCE: NCI Cancer Currents Blog
Can Topical Drugs Help Prevent Breast Cancer?
The drug tamoxifen can help prevent breast cancer in women at an increased risk of the disease. But many women who stand to benefit from tamoxifen do not take the drug—a pill—because of concerns about side effects, such as... Read More
POSTED: 12/04/2018SOURCE: NCI Cancer Currents Blog
Self-described “big fan” of the NCI Community Oncology Research Program (NCORP), NCI Director Norman (Ned) Sharpless, MD, welcomed investigators and administrators from the program to their annual meeting in late September... Read More
POSTED: 11/08/2018SOURCE: DCP News